Forschungsberichte

26.03.2021

HDAC6 inhibitors: Translating genetic and molecular insights into a therapy for axonal CMT

ElisabethRossaertab...Weiterlesen
28.02.2021

Molecular diagnosis of inherited peripheral neuropathies by targeted next-generation sequencing: molecular spectrum delineation

Juliette Bacquet et al., in: BMJ Open Vol 8 (2018) issue 10, https://bmjopen.bmj.com/content/8/10/e021632

Was ist die...Weiterlesen
07.02.2021

Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot–Marie–Tooth disease type 1A (CMT1A) rats

Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot–Marie–Tooth disease type 1A (CMT1A) rats

Prukop et al., 2020 :...Weiterlesen
07.02.2021

Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A)

Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A)

Prukop et al., 2019 :...Weiterlesen